Pieris Pharmaceuticals OKs 1-for-80 reverse stock split

seekingalpha04-20

Pieris Pharmaceuticals (NASDAQ:PIRS) said Friday it has approved a 1-for-80 reverse stock split of the company's common stock. The new CUSIP number following the reverse stock split will be 720795202....

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2428266908?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-04-20 00:23","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2428266908","market":"fut","top_or_hot":-1,"title":"Pieris Pharmaceuticals OKs 1-for-80 reverse stock split","media":"seekingalpha","content":"<div>\n<p>Pieris Pharmaceuticals (NASDAQ:PIRS) said Friday it has approved a 1-for-80 reverse stock split of the company's common stock.\nThe new CUSIP number following the reverse stock split will be 720795202....</p>\n\n<a href=\"https://seekingalpha.com/news/4091564-pieris-pharmaceuticals-oks-1-for-80-reverse-stock-split\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pieris Pharmaceuticals OKs 1-for-80 reverse stock split</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPieris Pharmaceuticals OKs 1-for-80 reverse stock split\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-20 00:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4091564-pieris-pharmaceuticals-oks-1-for-80-reverse-stock-split><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pieris Pharmaceuticals (NASDAQ:PIRS) said Friday it has approved a 1-for-80 reverse stock split of the company's common stock.\nThe new CUSIP number following the reverse stock split will be 720795202....</p>\n\n<a href=\"https://seekingalpha.com/news/4091564-pieris-pharmaceuticals-oks-1-for-80-reverse-stock-split\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://seekingalpha.com/news/4091564-pieris-pharmaceuticals-oks-1-for-80-reverse-stock-split","article_id":"2428266908","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2428266908","pubTimestamp":1713543829,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Pieris Pharmaceuticals  said Friday it has approved a 1-for-80 reverse stock split of the company's common stock.The new CUSIP number following the reverse stock split will be 720795202.The reverse stock split will be effective at 5:00 pm Eastern Time on April 22, 2024.More on Pieris Pharmaceuticals  Financial information for Pieris Pharmaceuticals","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","TQQQ":"纳指三倍做多ETF",".IXIC":"NASDAQ Composite","QID":"纳指两倍做空ETF","PSQ":"纳指反向ETF","QQQ":"纳指100ETF","QLD":"纳指两倍做多ETF","SQQQ":"纳指三倍做空ETF","PIRS":"Pieris Pharmaceuticals, Inc."},"translate_title":"Pieris Pharmaceuticals OKs 1/80反向股票分割","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PIRS":1,".IXIC":0.61,"MNQmain":0.6,"NQmain":0.6,"PSQ":0.6,"QID":0.6,"QLD":0.6,"QQQ":0.6,"SQQQ":0.6,"TQQQ":0.6},"content_text":"Pieris Pharmaceuticals (NASDAQ:PIRS) said Friday it has approved a 1-for-80 reverse stock split of the company's common stock.\nThe new CUSIP number following the reverse stock split will be 720795202. \nThe reverse stock split will be effective at 5:00 pm Eastern Time on April 22, 2024.\n\nPress Release.\n\n\nMore on Pieris Pharmaceuticals  Financial information for Pieris Pharmaceuticals","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2428266908"}